tirzepatide and increased heart rate Effects of tirzepatide, a dual GIP GLP-1 receptor agonist, on blood pressure, cardiac function, and sympathetic nervous system in stroke-prone spontaneously hypertensive rats Tirzepatide & Heart Rate: Cardiovascular

Total weekly exposure (AUC) stays roughly the same

It is important to monitor the patients sodium levels closely during administration as large amounts of saline can cause hypernatremia in certain individuals with impaired renal function

Ethics declarations Ethics approval and consent to participate We declare that all experiments on human subjects were conducted in accordance with the Declaration of Helsinki and that all procedures were carried out with the adequate understanding and written consent of the subjects

Monitoring parameters should include: Baseline and periodic assessment of renal function, as gastrointestinal side effects may lead to dehydration and acute kidney injury Blood glucose monitoring in diabetic patients, with adjustment of concomitant diabetes medications as needed Weight and nutritional status to ensure weight loss remains within healthy parameters MS symptom stability and functional status Patients should be advised to seek immediate medical attention for severe persistent abdominal pain (possible pancreatitis), signs of thyroid nodules, or symptoms of acute gallbladder disease